Learn More
BACKGROUND Attendance in screening is an important determinant of cervical cancer. Previous experience on high-risk human papillomavirus (hrHPV) DNA testing on patient-obtained samples suggests a good effect among nonattendees of screening. We assessed the effects of self-sampling on attendance in the Finnish screening program. METHODS Nonattendees after(More)
High coverage and attendance is essential for cervical cancer screening success. We investigated whether the previous positive experiences on increasing screening attendance by self-sampling in Finland are sampler device dependent. All women identified to cervical cancer screening in 2013 in 28 Finnish municipalities were randomised to receive a lavage- (n(More)
BACKGROUND Offering self-sampling to non-attendees of cervical screening increases screening attendance. METHODS We used observations from two Finnish studies on the use of self-sampling among the non-attendees to estimate in a hypothetical screening population of 100,000 women the possible costs per extra screened woman and costs per extra detected and(More)
  • 1